Entasis Therapeutics Completes Initial Closing of $35M Private Placement with Innoviva
WALTHAM, Mass., April 22, 2020 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) (“Entasis”), a clinical-stage biopharmaceutical company focused […]